Chemoinformaics analysis of Methyl 5-hexenoate
| Molecular Weight | 128.171 | nRot | 4 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 2 |
| Exact Molecular Weight | 128.084 | nRing | 0 |
| Solubility: LogS | -1.847 | nHRing | 0 |
| Solubility: LogP | 1.853 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 21.2955 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.326 |
| Synth | 2.044 |
| Natural Product Likeliness | 0.962 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.307 |
| MDCK | 0.0000367 |
| BBB | 0.999 |
| PPB | 0.621759 |
| VDSS | 0.752 |
| FU | 0.637573 |
| CYP1A2-inh | 0.694 |
| CYP1A2-sub | 0.628 |
| CYP2c19-inh | 0.263 |
| CYP2c19-sub | 0.829 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.724 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.553 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.269 |
| CL | 9.741 |
| T12 | 0.878 |
| hERG | 0.014 |
| Ames | 0.041 |
| ROA | 0.448 |
| SkinSen | 0.892 |
| Carcinogencity | 0.651 |
| EI | 0.977 |
| Respiratory | 0.431 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.951486 |